Minimed shares indicated at $20 each, IPO priced at $20

Minimed shares indicated at $20 each, IPO priced at $20

MiniMed Group (planned Nasdaq: MMED) has priced its initial public offering at $20.00 per share, raising $560 million through the sale of 28,000,000 shares. The IPO is expected to begin trading on Nasdaq on March 6, 2026, with the offering closing on March 9, 2026, subject to customary conditions. Underwriters have been granted a 30-day option to purchase up to 4,200,000 additional shares, which could increase total proceeds if exercised.

Following the IPO, Medtronic is anticipated to retain approximately 90.03% ownership of MiniMed. This stake would reduce to 88.70% if the underwriters fully exercise the over-allotment option. The company stated that proceeds from the offering will be allocated to general corporate purposes and may be used to repay intercompany debt owed to Medtronic.

The pricing of $20 per share aligns with the company's pre-IPO valuation expectations, reflecting investor interest in the medical technology sector. MiniMed's public listing follows a structured process, with trading commencing on the first business day outlined in the offering terms. Investors should note that the offering remains conditional, and final execution depends on standard regulatory and market requirements being met.

This transaction marks a significant step in MiniMed's capital-raising strategy while maintaining Medtronic's majority control over the entity.